Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
- Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)Active Not Recruiting
Sponsor: Genmab
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
United States, Argentina, Australia, Austria, Belgium +22 more
- Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)Active Not Recruiting
Sponsor: ML Bio Solutions, Inc.
Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
United States, Australia, Denmark, Germany, Italy +3 more
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
United States, Canada, France, Germany, Italy +4 more
- A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia AActive Not Recruiting
Sponsor: Novo Nordisk A/S
Haemophilia A · Haemophilia A With Inhibitors
United States, Austria, Belgium, Bulgaria, Canada +27 more
Sponsor: Hoffmann-La Roche
Von Willebrand Disease, Type 3
United States, Belgium, Canada, Colombia, France +9 more
- First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)Active Not Recruiting
Sponsor: Amgen
Extensive Stage Small Cell Lung Cancer
United States, Australia, Belgium, Canada, Denmark +10 more
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more
- CRS Questionnaire Validation ProjectRecruiting
Sponsor: The European Forum for Research and Education in Allergy and Airway Diseases
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
United States, Belgium, Canada, Denmark, Germany +6 more
Sponsor: Eli Lilly and Company
Ulcerative Colitis
United States, Austria, Brazil, Canada, China +12 more
Sponsor: AstraZeneca
Chronic Lymphocytic Leukaemia · Small Lymphocytic Lymphoma · Mantle-cell Lymphoma · Large B-cell Lymphoma
United States, Australia, China, Czechia, Denmark +8 more
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +24 more
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)Recruiting
Sponsor: Eli Lilly and Company
Irritable Bowel Syndrome · Diarrhea
United States, Belgium, Canada, China, Germany +5 more
Sponsor: InSightec
Breast Cancer
Germany
Sponsor: Gilead Sciences
Pre-Exposure Prophylaxis of HIV-1 Infection
United States, Austria, Canada, Denmark, France +6 more
Sponsor: Fondation Hôpital Saint-Joseph
Perimembranous Ventricular Septal Defect
Denmark, Egypt, France, Germany, Hong Kong +12 more
Sponsor: Eli Lilly and Company
Sleep Apnea, Obstructive · Obesity · Overweight
United States, Australia, Brazil, Canada, China +6 more
Sponsor: Akero Therapeutics, Inc
NASH - Nonalcoholic Steatohepatitis · MASH - Metabolic Dysfunction-Associated Steatohepatitis
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: Eli Lilly and Company
Lactation · Inflammatory Bowel Disease
United States, Canada, Denmark, Germany, Israel +2 more
- A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)Active Not Recruiting
Sponsor: Vertex Pharmaceuticals Incorporated
Cystic Fibrosis
United States, Australia, Belgium, Canada, Germany +2 more
Sponsor: BioNTech SE
Unresectable Head and Neck Squamous Cell Carcinoma · Metastatic Head and Neck Cancer · Recurrent Head and Neck Cancer
United States, Argentina, Australia, Austria, Belgium +16 more
Sponsor: AstraZeneca
ER-Positive HER2-Negative Breast Cancer
United States, France, Germany, Italy, Poland +4 more
Sponsor: Eli Lilly and Company
Osteoarthritis
United States, Canada, China, Germany, Japan +2 more
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial LinesActive Not Recruiting
Sponsor: Ipsen
Moderate to Severe Upper Facial Lines
France, Germany
- Observational Study Protocol: LIVER-RRecruiting
Sponsor: AstraZeneca
Hepatobiliary Cancers
United States, Australia, Austria, Belgium, Brazil +17 more
Sponsor: Bristol-Myers Squibb
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +15 more